Has Aken Desai, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,795 in general payments to Aken Desai, MD across 227 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Aken Desai, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Aken Desai, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Aken Desai, MD

Interventional Cardiology · Aurora, CONPI 1639464639

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 33.3% of the total.

$18,795in general payments, 2019–2025

Across 227 payments — averaging $82.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$6K
Edwards Lifesciences$6K
Medtronic$2K
W. L. Gore & Associates, Inc.$1K
Ancora Heart, Inc.$1K
Abiomed$528
plus $1K from 9 others

$51,967in research payments, 2019–2025

Across 32 payments — averaging $1623.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$52K

What the payments were for

Consulting fees$1,0005%
Travel & lodging$9,43350%
Food & beverage$8,36244%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	96	$6,262
Edwards Lifesciences	51	$5,733
Medtronic(2 entities)	24	$2,243
W. L. Gore & Associates, Inc.	26	$1,461
Ancora Heart, Inc.	3	$1,306
Abiomed	10	$528
Cardiovascular Systems Inc.	6	$415
Heartflow, Inc.	2	$330
Boston Scientific	3	$183
Penumbra, Inc.	1	$109
Asahi Intecc USA, Inc.	1	$84
Philips North America LLC	1	$57
Teleflex LLC	1	$39
Cardiva Medical, Inc.	1	$28
Stryker	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COREVALVE EVOLUT R$1,627
MitraClip$1,401
AccuCinch$1,306
Edwards SAPIEN 3 Transcatheter Heart Valve$1,267
CARDIOFORM Septal Occluder$1,025
Mitra Clip system$924
EVOQUE$784
PASCAL$428
Impella$350
FFRct$330
Xience V coronary stent system$289
AMPLATZER AMULET$241
CoreValve Evolut$160
TRICLIP$148
SAPIEN 3 Ultra RESILIA$147
Optis Coronary Imaging System$142
Peripheral Orbital Atherectomy System$131
ACUSEAL Vascular Graft$116
Indigo System$109
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$107

How this compares

$18,795 in reported general payments places this provider in the 70th percentile of 111 interventional cardiology providers in Colorado.

See all interventional cardiology providers in Colorado →

Medicare billing

Part B allowed, 2024

$141,652

Medicare patients

1,182

Services billed

2,082

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	31	$31,171
FarxigaDapagliflozin Propanediol	12	$19,610
JardianceEmpagliflozin	13	$18,848
Ezetimibe	40	$828
ClopidogrelClopidogrel Bisulfate	59	$718
Metoprolol Succinate	52	$536
Losartan Potassium	45	$322
Atorvastatin Calcium	40	$276
Carvedilol	22	$252
Rosuvastatin Calcium	21	$245
Amlodipine Besylate	23	$239
Metoprolol Tartrate	23	$232
Spironolactone	18	$180
Furosemide	13	$101
Amoxicillin	14	$17

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Aurora

Gareth MorganAurora$536K
Jamaluddin MolooAurora$272K
Jenny Zablah AlabiAurora$269K
Sridhar Sampath-KumarAurora$142K
Matthew ZipseAurora$137K
Jeffrey ParkAurora$132K
Akhil Rasim ReddyAurora$29K
John CarrollAurora$25K
Connie HessAurora$19K
Neel ButalaAurora$10K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →